FAQs

Business Office

Data Management, Inc (DMI)

Peoria Tazewell Pathology Group utilizes the services of Data Management, Inc (DMI), a leading provider of physician billing services for pathologists.

Privately owned and operated since 1976, DMI has a reputation as a highly respected and ethical physician billing service. By partnering with pathology groups, DMI works to provide the highest level of reimbursement through accurate coding, compliant claim submission and intensive payment follow-up and is committed to providing measurable results to our physician clients in the areas of coding, billing, collections, accounts receivable management and business intelligence reporting. These goals are achieved through the use of cutting-edge technology, ongoing education, friendly customer service and sincere communication. For more information, please call (309) 693-2620.

 

NewsPath - Pathology News for the Medical Community

Transformation of the Pathology Specialty

CAP STATLINE - Federal and State News

  • STATLINE Issue May 11, 2012
    In This Issue: CAP 2012 Policy Meeting Outlines Reform Challenges, Opportunities - CAP ACO White Paper Analyzes Pathologist’s Role in Improving Quality, Reducing Costs - CAP Outlines Stage 2 Meaningful Use Concerns to ONC, CMS - Mass. Lawmakers Propose Landmark Reforms in New Bills - Palmetto Delays MolDx Requirement till June 1, 2012 - Federal Appeals Court Sets July Date to Hear Myriad Case - Keep Up with the Latest CAP Advocacy News on Twitter
  • STATLINE Issue April 26, 2012
    In This Issue: 2011 Practice Characteristics Survey Now Available to CAP Members - AMA Immediate Past President Wilson to Address Payment Challenges at Policy Meeting - CAP Joins AMA, Physician Groups in Questioning CMS’s Proposed Overpayment Rule - CAP Teams With CDC to Enhance Tumor Biomarker Reporting to Cancer Registries - Arizona Scope-of Practice Legislation Signed Into Law - Keep Up with the Latest CAP Advocacy News on Twitter
  • STATLINE Issue April 12, 2012
    In This Issue: Self-Referral Study Links Financial Self Interest, Lower Cancer Detection - Energy & Commerce Committee Criticizes FDA's RUO/IUO Draft Guidance - CMS Names 27 ACO Participants for April Launch - MedPAC Takes Aim at Overvalued PFS Services - CAP Continues Pressing CMS to Suspend Palmetto’s MolDx Program - Connecticut Genetic Counselor Bill Stalled in Committee - Congressman Price (R-GA) To Address CAP Policy Meeting Attendees - Keep Up with the Latest CAP Advocacy News on Twitter
  • STATLINE Issue April 9, 2012
    Special Alert: New Evidence Links Self-Referral Labs to Increased Utilization, Lower Cancer Detection Rates

Peoria Tazewell Pathology Group
2011 All Rights Reserved

Designed by IE Media